iBio, Inc. (NYSEAMERICAN:IBIO – Get Rating) insider Martin Brenner sold 5,213 shares of the company’s stock in a transaction dated Thursday, March 23rd. The shares were sold at an average price of $2.13, for a total value of $11,103.69. Following the completion of the sale, the insider now owns 216,159 shares of the company’s stock, […]
iBio, Inc. (NYSEAMERICAN:IBIO – Get Rating) insider Martin Brenner sold 5,213 shares of iBio stock in a transaction that occurred on Thursday, March 23rd. The stock was sold at an average price of $2.13, for a total transaction of $11,103.69. Following the completion of the sale, the insider now owns 216,159 shares of the company’s […]
Zacks Investment Research upgraded shares of iBio (NYSEAMERICAN:IBIO – Get Rating) from a sell rating to a hold rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch […]